Position in HLN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,077,883
-$196,698 QoQ
Shares Held
329,891
+0.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $131,969,402 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,604,027 | $26,040,270 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
398,266 | $25,469,110 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
135,104 | $22,770,428 | |
| 4 | ALKS |
Alkermes plc.
|
419,102 | $21,960,944 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
33,836 | $18,333,359 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
247,474 | $11,698,095 | |
| 7 | HLN |
Haleon plc
This page
|
329,891 | $3,077,883 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
180,767 | $2,619,313 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,077,883 | 329,891 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $3,274,581 | 327,131 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,184,609 | 314,996 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,974,631 | 331,620 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,671,405 | 354,041 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,980,933 | 386,874 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,188,012 | 438,995 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $144,758,331 | 13,682,262 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $115,370,021 | 13,967,315 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $122,054,812 | 14,376,303 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $121,291,896 | 14,737,776 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $126,319,377 | 15,164,391 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $141,621,522 | 16,899,943 | Shares | Defined | 2023-12-12 | |
| 2023-03-31 | $140,805,671 | 17,297,994 | Shares | Defined | 2023-12-12 | |
| 2022-12-31 | $142,204,912 | 17,775,614 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $117,474,888 | 19,289,801 | Shares | Defined | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||